Imaging Biometrics soars on results from glioblastoma treatment trial
(Alliance News) - Imaging Biometrics Ltd on Monday said it has successfully completed the phase one trial evaluating oral gallium maltolate for the treatment of recurrent or relapsed glioblastoma. Read More